{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:17:01Z","timestamp":1783199821749,"version":"3.54.6"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["24xkjc016"],"award-info":[{"award-number":["24xkjc016"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515011034"],"award-info":[{"award-number":["2025A1515011034"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022B1515130008"],"award-info":[{"award-number":["2022B1515130008"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574428"],"award-info":[{"award-number":["82574428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272968"],"award-info":[{"award-number":["82272968"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304520"],"award-info":[{"award-number":["82304520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbrc.2026.154043","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:30:53Z","timestamp":1779838253000},"page":"154043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["O-GlcNAcylation of NSD2 promotes lung metastasis of triple-negative breast cancer through extracellular matrix remodeling"],"prefix":"10.1016","volume":"827","author":[{"given":"Sicheng","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufeng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junguo","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5031-6593","authenticated-orcid":false,"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154043_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.154043_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154043_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","article-title":"Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment","volume":"9","author":"Garrido-Castro","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2026.154043_bib4","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cncr.22836","article-title":"Differences in breast carcinoma characteristics in newly diagnosed African\u2013American and Caucasian patients","volume":"110","author":"Morris","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2026.154043_bib5","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154043_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-10168-4","article-title":"Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria","volume":"22","author":"Deutschmann","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154043_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1634\/theoncologist.2014-0002","article-title":"Measures of outcome in metastatic breast cancer: insights from a real-world scenario","volume":"19","author":"Bonotto","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.bbrc.2026.154043_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199714","article-title":"Triple-negative breast cancer unveiled: bridging science, treatment strategy, and economic aspects","volume":"26","author":"Lebedeva","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154043_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbrc.2026.154043_bib10","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.154043_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer \u2014 expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154043_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154043_bib13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154043_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in targeted strategies for triple-negative breast cancer","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154043_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154043_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154043_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/COC.0000000000000919","article-title":"Sacituzumab govitecan-hziy in breast cancer","volume":"45","author":"Kwapisz","year":"2022","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154043_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cell.2018.08.058","article-title":"Targeting epigenetic crosstalk as a therapeutic strategy for EZH2-Aberrant solid tumors","volume":"175","author":"Huang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154043_bib19","article-title":"Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: from underlying mechanisms to targeted therapeutics","volume":"1878","author":"Jin","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrc.2026.154043_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41580-022-00518-2","article-title":"Regulation, functions and transmission of bivalent chromatin during mammalian development","volume":"24","author":"Macrae","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154043_bib21","article-title":"Starvation-induced HBP metabolic reprogramming and STAM2 O-GlcNAcylation facilitate bladder cancer metastasis","volume":"15","author":"Feng","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154043_bib22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/epi.15.32","article-title":"The NSD family of protein methyltransferases in human cancer","volume":"7","author":"Vougiouklakis","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.bbrc.2026.154043_bib23","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.2147\/OTT.S259873","article-title":"The role of methyltransferase NSD2 as a potential oncogene in human solid tumors","volume":"13","author":"Chen","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2026.154043_bib24","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/ng.2777","article-title":"Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia","volume":"45","author":"Jaffe","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2026.154043_bib25","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1182\/blood-2002-06-1675","article-title":"Multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression","volume":"101","author":"Keats","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.154043_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2016.05.004","article-title":"Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes","volume":"378","author":"Wang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154043_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41401-018-0199-z","article-title":"Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling","volume":"40","author":"Wang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2026.154043_bib28","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1080\/15548627.2025.2479995","article-title":"H3K36me2 methyltransferase NSD2\/WHSC1 promotes triple-negative breast cancer metastasis via activation of ULK1-dependent autophagy","volume":"21","author":"Chen","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2026.154043_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110201","article-title":"O-GlcNAcylation regulation of cellular signaling in cancer","volume":"90","author":"Ciraku","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.154043_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4149\/neo_2020_191006N1009","article-title":"O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells","volume":"67","author":"Jin","year":"2020","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbrc.2026.154043_bib31","first-page":"3013","article-title":"Eek-hoon jho O-GlcNAcylation: an emerging protein modification regulating the hippo pathway","volume":"12","author":"Eunah Kim","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.154043_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12672-021-00450-5","article-title":"O-GlcNAcylation links oncogenic signals and cancer epigenetics","volume":"12","author":"Sun","year":"2021","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbrc.2026.154043_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215365","article-title":"Role and function of O-GlcNAcylation in cancer","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.154043_bib34","doi-asserted-by":"crossref","first-page":"13009","DOI":"10.1074\/jbc.M801222200","article-title":"AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation","volume":"283","author":"Cheung","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154043_bib35","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1074\/jbc.M803198200","article-title":"Up-regulation of O-GlcNAc transferase with glucose deprivation in HepG2 cells is mediated by decreased hexosamine pathway flux","volume":"284","author":"Taylor","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154043_bib36","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1074\/jbc.M707328200","article-title":"Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase","volume":"283","author":"Taylor","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154043_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"Minn","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154043_bib38","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s44321-024-00108-z","article-title":"Therapeutic targeting ERR\u03b3 suppresses metastasis via extracellular matrix remodeling in small cell lung cancer","volume":"16","author":"Wang","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154043_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-14495-x","article-title":"Substrate stiffness regulates triple-negative breast cancer signaling through CXCR4 receptor dynamics","volume":"15","author":"Ho","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154043_bib40","article-title":"O-GlcNAcylation-regulated classical programmed cell death in diseases: molecular crosstalk and therapeutic opportunities","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154043_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114394","article-title":"UBR7 in concert with EZH2 inhibits the TGF-\u03b2 signaling leading to extracellular matrix remodeling","volume":"43","author":"Adhikari","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.154043_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/10799893.2020.1747490","article-title":"WHSC1 promotes wnt\/\u03b2-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer","volume":"40","author":"Zhang","year":"2020","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.bbrc.2026.154043_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-07370-w","article-title":"Recent progress in immune evasion mechanisms of triple-negative breast cancer","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154043_bib44","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41423-025-01321-7","article-title":"Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy","volume":"22","author":"Zou","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbrc.2026.154043_bib45","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41401-018-0199-z","article-title":"Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling","volume":"40","author":"Wang","year":"2019","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:58:01Z","timestamp":1783198681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26008077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S0006291X26008077"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154043","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"O-GlcNAcylation of NSD2 promotes lung metastasis of triple-negative breast cancer through extracellular matrix remodeling","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154043"}}